These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24419144)

  • 21. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling.
    Chang CH; Lee CY; Lu CC; Tsai FJ; Hsu YM; Tsao JW; Juan YN; Chiu HY; Yang JS; Wang CC
    Int J Oncol; 2017 Mar; 50(3):873-882. PubMed ID: 28197628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway.
    Fu Y; Chang H; Peng X; Bai Q; Yi L; Zhou Y; Zhu J; Mi M
    PLoS One; 2014; 9(7):e102535. PubMed ID: 25068516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol as sensitizer in colorectal cancer plasticity.
    Brockmueller A; Sajeev A; Koklesova L; Samuel SM; Kubatka P; Büsselberg D; Kunnumakkara AB; Shakibaei M
    Cancer Metastasis Rev; 2024 Mar; 43(1):55-85. PubMed ID: 37507626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.
    Tan L; Wang W; He G; Kuick RD; Gossner G; Kueck AS; Wahl H; Opipari AW; Liu JR
    Cancer; 2016 Mar; 122(5):722-9. PubMed ID: 26619367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol inhibits TIGAR to promote ROS induced apoptosis and autophagy.
    Kumar B; Iqbal MA; Singh RK; Bamezai RN
    Biochimie; 2015 Nov; 118():26-35. PubMed ID: 26212201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol-induced apoptosis is mediated by early growth response-1, Krüppel-like factor 4, and activating transcription factor 3.
    Whitlock NC; Bahn JH; Lee SH; Eling TE; Baek SJ
    Cancer Prev Res (Phila); 2011 Jan; 4(1):116-27. PubMed ID: 21205742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective molecular mechanisms of resveratrol in UVR-induced Skin carcinogenesis.
    Aziz SW; Aziz MH
    Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):35-41. PubMed ID: 28767162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo.
    Garvin S; Ollinger K; Dabrosin C
    Cancer Lett; 2006 Jan; 231(1):113-22. PubMed ID: 16356836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A perspective on chemoprevention by resveratrol in head and neck squamous cell carcinoma.
    Shrotriya S; Agarwal R; Sclafani RA
    Adv Exp Med Biol; 2015; 815():333-48. PubMed ID: 25427916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.
    Patel KR; Brown VA; Jones DJ; Britton RG; Hemingway D; Miller AS; West KP; Booth TD; Perloff M; Crowell JA; Brenner DE; Steward WP; Gescher AJ; Brown K
    Cancer Res; 2010 Oct; 70(19):7392-9. PubMed ID: 20841478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol exerts differential effects in vitro and in vivo against ovarian cancer cells.
    Stakleff KS; Sloan T; Blanco D; Marcanthony S; Booth TD; Bishayee A
    Asian Pac J Cancer Prev; 2012; 13(4):1333-40. PubMed ID: 22799328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo.
    Fukui M; Yamabe N; Zhu BT
    Eur J Cancer; 2010 Jul; 46(10):1882-91. PubMed ID: 20223651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal cancer chemoprevention by trans-resveratrol.
    Juan ME; Alfaras I; Planas JM
    Pharmacol Res; 2012 Jun; 65(6):584-91. PubMed ID: 22465196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells.
    Hong EH; Heo EY; Song JH; Kwon BE; Lee JY; Park Y; Kim J; Chang SY; Chin YW; Jeon SM; Ko HJ
    Oncotarget; 2017 Jun; 8(25):41401-41411. PubMed ID: 28489607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway.
    Zhang B; Yin X; Sui S
    Oncol Rep; 2018 Nov; 40(5):2758-2765. PubMed ID: 30132535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chemopreventive agent resveratrol stimulates cyclic AMP-dependent chloride secretion in vitro.
    Blumenstein I; Keserü B; Wolter F; Stein J
    Clin Cancer Res; 2005 Aug; 11(15):5651-6. PubMed ID: 16061885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol.
    Fulda S; Debatin KM
    Cancer Res; 2004 Jan; 64(1):337-46. PubMed ID: 14729643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological effects of resveratrol.
    Frémont L
    Life Sci; 2000 Jan; 66(8):663-73. PubMed ID: 10680575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
    Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
    Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity.
    Jeong JK; Moon MH; Bae BC; Lee YJ; Seol JW; Kang HS; Kim JS; Kang SJ; Park SY
    Neurosci Res; 2012 Jun; 73(2):99-105. PubMed ID: 22465415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.